Evidence map›Paper›PMID 37587128›Full record

ArticleScientific reports2023

Two sequence- and two structure-based ML models have learned different aspects of protein biochemistry.

Anastasiya V Kulikova, Daniel J Diaz, Tianlong Chen, T Jeffrey Cole, Andrew D Ellington, Claus O Wilke

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anastasiya V KulikovaDepartment of Integrative Biology, University of Texas at Austin, Austin, TX, USA.
Daniel J DiazDepartment of Chemistry, The University of Texas at Austin, Austin, TX, USA.
Tianlong ChenInstitute for Foundations of Machine Learning (IFML), The University of Texas at Austin, Austin, TX, USA.
T Jeffrey ColeDepartment of Integrative Biology, University of Texas at Austin, Austin, TX, USA.
Andrew D EllingtonThe Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX, USA.ORCID http://orcid.org/0000-0001-6246-5338
Claus O WilkeDepartment of Integrative Biology, University of Texas at Austin, Austin, TX, USA. wilke@austin.utexas.edu.ORCID http://orcid.org/0000-0002-7470-9261

Funding

Investigating nanobodies to target multidrug resistant bacterial pathogensR01AI148419 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI DAVIES, BRYAN WILLIAM · 2020 to 2023
$2.8M
NIAID NIH HHS R01 AI148419
6 · The paper itself

Abstract

Deep learning models are seeing increased use as methods to predict mutational effects or allowed mutations in proteins. The models commonly used for these purposes include large language models (LLMs) and 3D Convolutional Neural Networks (CNNs). These two model types have very different architectures and are commonly trained on different representations of proteins. LLMs make use of the transformer architecture and are trained purely on protein sequences whereas 3D CNNs are trained on voxelized representations of local protein structure. While comparable overall prediction accuracies have been reported for both types of models, it is not known to what extent these models make comparable specific predictions and/or generalize protein biochemistry in similar ways. Here, we perform a systematic comparison of two LLMs and two structure-based models (CNNs) and show that the different model types have distinct strengths and weaknesses. The overall prediction accuracies are largely uncorrelated between the sequence- and structure-based models. Overall, the two structure-based models are better at predicting buried aliphatic and hydrophobic residues whereas the two LLMs are better at predicting solvent-exposed polar and charged amino acids. Finally, we find that a combined model that takes the individual model predictions as input can leverage these individual model strengths and results in significantly improved overall prediction accuracy.

Indexed as

Amino AcidsAntifibrinolytic AgentsAmino Acid SequenceElectric Power SuppliesLanguageAmino AcidsAntifibrinolytic Agents

Identifiers

PMID37587128
PMCPMC10432456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.